Marker Therapeutics Inc Share Price

NASDAQ: MRKR

Small Cap

$0.94

-0.01

(-1.07%)

Live

as on September 16, 2025 at 7:32 pm IST

$₹

Marker Therapeutics Inc Stock Performance

as on September 16, 2025 at 7:32 pm IST

Day's Low
Day's High
$0.92
Day's Price Range
$0.97
$0.94
2.13%
Downside
3.19%
Upside
52 Week's Low
52 Week's High
$0.81
52-Week Price Range
$5.95
$0.94
13.84%
Downside
532.98%
Upside

Marker Therapeutics Inc share price movements today

Previous Close: $0.95
Open: $0.94
Volume: 56.2K
Day's Low - High: $0.92 - $0.97
52 Week Low - High: $0.81 - $5.95

Marker Therapeutics Inc Historical Returns

1 Month Return: -24.93 %
3 Month Return: -37.77 %
1 Year Return: -67.16 %
3 Year Return: -79.21 %
5 Year Return: -94.4 %

Marker Therapeutics Inc Stock Fundamentals & Key Indicators

Check Marker Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.4M

EPS (TTM)

-1.08

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-11.8M

Revenue (TTM)

5.4M

Profit Margin

-271.11%

Return On Equity TTM

22958600.00%

Marker Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Marker Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Marker Therapeutics Inc	BUY	$12.4M	-94.4%	NA	-271.11%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Marker Therapeutics Inc Stock including INR - Dollar returns

The Marker Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Marker Therapeutics Inc investment value today

Current value as on today

₹37,506

Returns

₹62,494

(-62.49%)

Returns from Marker Therapeutics Inc Stock

₹67,361 (-67.36%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Marker Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Marker Therapeutics Inc. Average target price of $6

Marker Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Marker Therapeutics Inc.

What analysts predicted

84.33%UPSIDE

Target Price

Current Price

$0.94

Analyzed by

7 Analysts

Target

$6.00

Marker Therapeutics Inc target price $6, a slight upside of 84.33% compared to current price of $0.94. According to 7 analysts rating.

Marker Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Marker Therapeutics Inc Stock has decreased by -72% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-72% versus previous 30 day period

Marker Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	3	0	0	1	1	1	1	2	0	0
Gross Profit	3	-1	-1	-1	-1	-1	-1	-2	0	-
Operating Income	-5	-4	-3	-2	-2	-2	-2	-3	-4	-4
EBITDA	-3	-4	-3	-2	-2	-2	-2	2	-4	-4
Interest Expense	0	-	-	0	-	-	-	0	-	-
Depreciation	0	-	-	-	-	-	-	-	-	-
Income Before Tax	-4	-4	-2	-2	-2	-2	-2	-3	-4	-4
Income Tax Expense	0	-4	0	0	-2	-	-	0	-	-
Net Income	-4	2	-2	-2	-2	-2	-2	-3	-4	-4
Net Profit Margin	-139.54%	329.90%	-1157.58%	-265.18%	-192.36%	-187.60%	-119.83%	-170.43%	-1273.55%	-466.28%

Marker Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	0	0	0	0	1	9	3	6
Gross Profit	-	-	-5	-123	-12	-18	-1	5	-7	-6
Operating Income	-6	-8	-11	-148	-22	-28	-39	-19	-14	-11
EBITDA	-34	6	-11	-147	-22	-27	-36	-19	-11	-4
Interest Expense	0	-	-	-	-	0	0	0	-	-
Depreciation	-	-	-	-	0	1	3	3	-	-
Income Before Tax	-34	-2	-10	-147	-21	-28	-41	-19	-14	-10
Income Tax Expense	27	-6	0	0	-1	0	0	0	0	0
Net Income	-34	-2	-10	-147	-21	-28	-41	-29	-8	-10
Net Profit Margin	0.00%	0.00%	-5998.99%	-71826.36%	-10050.94%	-6149.73%	-3371.90%	-332.38%	-248.78%	-162.81%

Marker Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	-2	-2	-2	-2	-2	-3	-4	-4
Operating Cash Flow	-7	-1	-2	-3	-3	1	-4	-5	-1
Investing Cash Flow	18	18	-18	-	-	-	-	-	-
Financing Cash Flow	0	0	0	0	0	0	14	0	0
Change in Cash	11	0	-2	-3	-3	1	10	-5	-1

Marker Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-10	-147	-21	-28	-41	-29	-14	-10
Operating Cash Flow	-6	-8	-14	-18	-18	-27	-26	-16	-10
Investing Cash Flow	0	0	0	0	-10	-3	-4	18	-
Financing Cash Flow	7	5	71	0	6	52	0	1	14
Change in Cash	1	-2	56	-17	-22	22	-31	3	4

Global Institutional Holdings in Marker Therapeutics Inc

Funds	Holdings
NEA Management Company, LLC	14.37%
Blue Owl Capital Holdings LP	4.9%
Hudson Bay Capital Management LP	4.42%
Aisling Capital Management LP	2.88%
Vanguard Group Inc	2.43%

See all

Insights on Marker Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 349.10K → 861.18K (in $), with an average increase of 59.5% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -4.44M → -4.01M (in $), with an average increase of 10.7% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, MRKR stock has moved up by 11.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 195.7%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 137.8%

About Marker Therapeutics Inc

tapimmune is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. the company’s next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches and has the potential to be a powerful standalone therapy or part of a leading combination regimen by complementing other approved or development-stage immunotherapeutics (i.e. checkpoint inhibitors). the company’s off-the-shelf vaccines boost patients’ immune systems to comprehensively stimulate both killer t-cells and helper t-cells to destroy cancer cells, and they are designed to work with 80% of the population. tapimmune is advancing two clinical stage t-cell vaccine candidates in multiple phase ii and phase ib/iia clinical trials for treating ovarian and breast cancers, including programs in ovarian cancer that will benefit from fda fast track and orphan disease designation. the company is working in collaboration with industry and clini

Organisation	Marker Therapeutics Inc
Headquarters	2450 Holcombe Blvd, Houston, TX, United States, 77021
Industry	Consumer Services
CEO	Dr. Juan F. Vera M.D.
E-voting on shares	Click here to vote

Key Management of Marker Therapeutics Inc

Name	Title
Ms. Elizabeth Donnelly	Director of Administration
Dr. Maria-Bernadette Madel Ph.D.	Director of Corporate Operations & External Communications
Mr. Edmund Cheung	Vice President of Human Resources
Patricia Allison	Head of Clinical Operations
Ms. Mary Newman Ph.D.	Head of Regulatory Affairs
Dr. Robert Z. Florkiewicz Sr., Ph.D.	Senior Director of Molecular Biology & Virology
Dr. Juan F. Vera M.D.	Co-Founder, CEO, President, Treasurer, Secretary & Director

FAQs

What is Marker Therapeutics Inc share price today?

Marker Therapeutics Inc share price today is $0.94 as on September 16, 2025 at 7:32 pm IST. Marker Therapeutics Inc share today touched a day high of $0.97 and a low of $0.92.

What is the 52 week high and 52 week low for Marker Therapeutics Inc share?

Marker Therapeutics Inc share touched a 52 week high of $5.95 on December 17, 2024 and a 52 week low of $0.81 on August 28, 2025. Marker Therapeutics Inc stock price today i.e. September 16, 2025 at 7:32 pm IST is trending at $0.94,which is 84.20% down from its 52 week high and 16.06% up from its 52 week low.

What is Marker Therapeutics Inc's market capitalisation today?

Marker Therapeutics Inc market capitalisation is $0.00T as on September 16, 2025 at 7:32 pm IST.

How to invest in Marker Therapeutics Inc Stock (MRKR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Marker Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Marker Therapeutics Inc Shares that will get you 1.5957 shares as per Marker Therapeutics Inc share price of $0.94 per share as on September 16, 2025 at 7:32 pm IST.

What is the minimum amount required to buy Marker Therapeutics Inc Stock (MRKR) from India?

Indian investors can start investing in Marker Therapeutics Inc (MRKR) shares with as little as ₹88.042 or $1 (as of September 16, 2025 at 7:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Marker Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 7:42 pm IST). Based on Marker Therapeutics Inc share’s latest price of $0.94 as on September 16, 2025 at 7:32 pm IST, you will get 10.6383 shares of Marker Therapeutics Inc. Learn more about fractional shares .

What are the returns that Marker Therapeutics Inc has given to Indian investors in the last 5 years?

Marker Therapeutics Inc stock has given -94.4% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?